Table 1. Correlation between the clinicopathologic variables and Sun2 expression in prostate caner.
| Clinical character | Cases | Sun2 expression | Low | χ2value | p value |
|---|---|---|---|---|---|
| High | |||||
| Age (years) | |||||
| < 60 | 31 (34.4%) | 11 (35.5%) | 20 (64.5%) | 0.23 | 0.64 |
| ≥ 60 | 59 (65.6%) | 18 (30.5%) | 41 (69.5%) | ||
| Gleason score | |||||
| < 8 | 58 (64.5%) | 24 (41.3%) | 34 (58.7%) | 6.26 | 0.018* |
| ≥ 8 | 32 (35.5%) | 5 (15.7%) | 27 (84.3%) | ||
| PSA at diagnosis (ng/ml) | |||||
| < 10 | 41 (45.6%) | 10 (24.4%) | 31 (75.6%) | 2.11 | 0.178 |
| ≥ 10 | 49 (54.4%) | 19 (38.8%) | 30 (61.2%) | ||
| Tumor infiltration | |||||
| T1–T2 | 50 (55.6%) | 20 (33.3%) | 30 (66.7%) | 5.31 | 0.03* |
| T3–T4 | 40 (44.4%) | 9 (66.2%) | 31 (33.8%) | ||
| Lymph nodal status | |||||
| Negative | 48 (53.3%) | 22 (45.8%) | 26 (54.2%) | 8.7 | 0.004** |
| Positive | 42 (46.7%) | 7 (16.7%) | 35 (83.3%) | ||
| Clinical pathological stage | |||||
| < T2C | 54 (60%) | 23 (44.6%) | 31 (55.4%) | 6.65 | 0.012* |
| ≥ T2C | 36 (40%) | 6 (16.7%) | 30 (83.3%) | ||
| Total | 90 (100.0%) | 29 (32.2%) | 61 (67.8%) |
Statistical analyses were carried out using Pearson χ2 test.
*P < 0.05 and **P < 0.01 were considered significant.